Abstract:OBJECTIVE To investigate the role of human transcription factor NF-E2-related factor 2 (Nrf2) in the induction of the gene expression of uridine 5'-diphosphate-glucuronosyltransferase (UGT) 1A and its isoforms by epigallocatechin gallate (EGCG). METHODS (1) Human colon carcinoma cells Caco-2 and HT-29 were cultured. Immunocytochemistry, western blotting and confocal laser microscopy were used to detect the protein expression of Nrf2. Twenty samples of colon carcinoma with surrounding normal tissues were collected during endoscopic course. (2) RNA interference expression vector pSilencer 3.1-H1 was used to construct four Nrf2-trageting plasmids: pSilence-Nrf2-A, B, C, and D and a control pSilence-CON. Cells were transfected with pSilence-Nrf2 for 48 hours to observe the effects of transient transfection. Cells were stably transfected with pSilence-Nrf2-B for 4 weeks and re-named as Caco-2-siNrf2 and HT-29-siNrf2 (siNrf2 cells), and others stably transfected with blank plasmid pSilencer 3.1-H1 were used as controls. (3) EGCG was added into the culture fluid of cells before and after the stably transfection. RT-PCR was used to detect the mRNA expression of Nrf2, UGT1A, UGT1A8 and UGT1A10 in cells and the samples of human colon cancer tissue. RESULTS (1) The expressions of UGT1A8 and UGT1A10 mRNA were significantly lower than that in the surrounding healthy mucosa. (2) The mRNA expression of Nrf2, UGT1A8, and UGT1A10 increased by 1.8-9.2 times after the addition of EGCG (all P < 0.05). Immunocytochemistry, western blotting and immunofluorescence demonstrated a significant increase of Nrf2 protein expression in the nucleus after treatment with EGCG. (3) SalIenzyme digestion and DNA sequencing confirmed that pSilence-Nrf2-A, B, C, and D and pSilence-CON were all successfully constructed. The inhibition rate of Nrf2 gene expression was above 80% 48 h after transfection with pSilence-Nrf2-B, and that was no significant difference after transfection with pSilence-CON (P > 0.05). There was specific inhibition of Nrf2 in Caco-2-siNrf2, HT-29-siNrf2 cells (both P < 0.01). (4) The basal levels of UGT1A8 and UGT1A10 mRNA expression in the Caco-2-siNrf2 and HT-29-siNrf2 cells were lower by 15%-65% in comparison with those in control, and the induction of genes by EGCG was largely attenuated in them (all P > 0.05). CONCLUSION Nrf2 is localized in the cytoplasm of non-stimulated cells, and EGCG triggered its rapid nuclear accumulation. Suppression of Nrf2 gene expression results in down-regulation of the constructive expression of UGT genes and their induction by EGCG. EGCG induces the expression of UGT1A, UGT1A8 and UGT1A10 genes via a Nrf2-dependent mechanism.

Inhibition of NRF2 Expression by RNAi in Caco-2 Cells

Construction of RNA interfering expression vector directed against Nrf2

Bioengineered NRF2-siRNA is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

Inhibiting Tumor Growth of Colorectal Cancer by Blocking the Expression of Vascular Endothelial Growth Factor Receptor 3 Using Interference Vector-Based RNA Interference

Combining Sirnas at Two Different Sites in the Egfr to Suppress Its Expression, Induce Apoptosis, and Enhance 5-Fluorouracil Sensitivity of Colon Cancer Cells

Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference

Inhibition of Epidermal Growth Factor Receptor Expression by RNA Interference in A549 Cells

Construction and Identification of Two Psuper RNAi Systems of Inhibiting HIF -1Α Activity of Prostate Cancer

P-0079 Nrf2 Knockdown by Sirna Enhance the Sensitivity to Chemotherapy in Hepatocellular Carcinoma

Effect of targeting inhibition of epidermal growth factor receptor expression by RNA interference on the proliferation of colon cancer cells

The Role of Nrf2 in the Expression of UGT1A and Its Isoforms Induced by EGCG in Colon Tumor

Construction and Identification of the Small Interfering RNA Eukaryotic Expression Vectors of Human ClC-2 Gene

Inhibition of tumor growth of non-small cell lung cancer by small interfering RNA targeting to HER2/neu gene

The Inhibition Effect of HIF-1α Sirna on VEGF Mrna Expression in Vitro

STUDY ON INHIBITION OF EXPRESSION OF HUMAN NUCLEAR RECEPTOR NR5A2 VIA RNA INTERFERENCE MEDIATED BY SIRNA EXPRESSING VECTOR

Construction of eukaryotic expression vector of siRNA specific for hnRNP K and characterization of its efficiency in A549 lung carcinoma cell line

[The Role of NF-E2-related Factor 2 in the Induction of Uridine 5'-Diphosphate-glucuronosyltransferase 1A and Its Isoforms by Epigallocatechin Gallate in Colon Cancer Cells].

Inhibition of green fluorescent protein expression by short hairpin RNA expression vector in human breast cancer cells(MCF-7/AdrR)

Construction of Expressing Vector of Psuper-Shrna/mrp1 and Its Expression in Vitro

Construction of lentiviral vector of peroxiredoxin 2 gene mediating RNAi and its effects on the proliferation of SW480 cell

Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells